Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat in Hemodialysis Patients with Anemia (ASPEN)
NCT04484857Phase 3Completed
- Sponsor
- FibroGen
- Start
- Jul 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roxadustat in anemia of chronic kidney disease (CKD-A), sponsored by FibroGen. Started Jul 2020; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT04484857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04484857.